Android app on Google Play

Onyx Pharmaceuticals, Inc. (ONXX) Reports Stronger-Than-Expected Q4 Results

February 22, 2012 4:16 PM EST Send to a Friend
Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) reported Q4 EPS of $1.50, $0.07 better than the analyst estimate of $1.43. Revenue for the quarter came in at $237 million versus the consensus estimate of $213.24 million.

For earnings history and earnings-related data on Onyx Pharmaceuticals, Inc. (ONXX) click here.

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment